Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians
NCT ID: NCT06626672
Last Updated: 2025-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-10-01
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digital Health Nudging in Adolescents With Congenital Heart Disease
NCT04933786
Web-based Motor Intervention to Increase Health Related Physical Fitness in Children With Congenital Heart Disease
NCT03488797
Digital Cardiovascular Health Promotion Among School-going Adolescents in Nepal
NCT06668675
Wearable Technology for Personalised Physical Activity Feedback in Cardiac Patients: a Feasibility Study
NCT05605015
Start-to-Sport - Home-based Exercise for Adolescents and Adults With Congenital Heart Disease
NCT02240147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Digital Health Intervention
Children and their guardians are given access to a 12-week digital platform with content to improve their lifestyle.
Physical activity is monitored with a Garmin Vivofit Jr. 2.
Digital Health Intervention
Access to a digital platform including weekly workout videos, live workouts, recipes, study summaries, and a consultation hour.
Control
During 12-week control period participants receive no access the digital platform. Physical activity is monitored with a Garmin Vivofit Jr. 2.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital Health Intervention
Access to a digital platform including weekly workout videos, live workouts, recipes, study summaries, and a consultation hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of a congenital heart defect (must be moderate or complex according to ACC criteria)
* NYHA Class I or II
* Presence of written informed consent
Exclusion Criteria
* No sports clearance by paediatric cardiologists
8 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technical University of Munich
OTHER
Stiftung KinderHerz Deutschland gGmbH
UNKNOWN
Deutsches Herzzentrum Muenchen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Müller, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Technical University of Munich, Chair of preventive perdiatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Paediatric Cardiology and Congenital Heart Defects, German Heart Center of the State Bavaria (Munich), Technical University of Munich (TUM)
München, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-337-S-SB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.